Skip to main content
. Author manuscript; available in PMC: 2020 Jun 11.
Published in final edited form as: Immunometabolism. 2020 May 7;2(3):e200019. doi: 10.20900/immunometab20200019

Table 4.

l,25-(OH)2D3 regulation of CD4+ T cell gene expression a.

GENE SPECIES REFERENCES
Enhanced gene expression
Bhmtl * mouse [32]
CCR2 human [170]
Ctla4* mouse [31,171]
CTLA4* human [170,172175]
CXCR3 human [170]
Cyp24al* mouse [176]
CYP24A1* human [177,178]
CYP27B1 human [177]
Foxp3* mouse [82,171,176,179]
FOXP3* human [170,172174,179182]
Ikzf2* mouse [32,82,176]
Il10 mouse [171,173,179,183,184]
IL10 human [170,174,179,185187]
IL10RA human [170]
IL2RA* human [174,178]
ITGA2 human [170]
LAG3 human [170]
MGAT1 human [188]
PLCG1 human [189]
Tgfb mouse [171,190]
Vdr* mouse [176,191193]
VDR* human [173,177]
Diminished gene expression
CCR6 human [170]
Hiflα mouse [194]
Ifng mouse [82,195]
IFNG human [170,172,177,186]
Il17 mouse [82,173,184,190,193,195199]
IL17F human [170,172,173,186,187]
IL21 human [172]
1122 mouse [173]
IL22 human [170,184,187]
IL26 human [170]
Il23r mouse [184]
Rorc mouse [184,190]
TAGAP* human [178]
a

This table includes only protein-coding genes.

*

The indicates the gene control regions include an established or postulated VDRE. Regulation of CD4+ T cell gene expression has been investigated in vitro and in vivo using experimental approaches that measure direct transcriptional regulation or indirect influences on gene expression (changes in cell differentiation, epigenetic marks, and non-coding RNAs). We refer the interested reader to the original reports for the experimental details and findings.